Protocol Specific Research Support

$53,025P30FY2015CANIH

Virginia Commonwealth University, Richmond VA

Investigators

Linked publications, trials & patents

Paper 39574605 Paper 39554866 Paper 39417215 Paper 39415933 Paper 39415072 Paper 39379134 Paper 39345623 Paper 39345509 Paper 39314417 Paper 39303845 Paper 39302104 Paper 39293568 Paper 39279661 Paper 39277599 Paper 39269177 Paper 39263826 Paper 39185537 Paper 39156950 Paper 39074146 Paper 39005390 Paper 38979255 Paper 38978567 Paper 38959068 Paper 38925249 Paper 38909784 Paper 38903113 Paper 38895230 Paper 38883782 Paper 38775127 Paper 38750629 Paper 38743566 Paper 38719150 Paper 38712133 Paper 38712089 Paper 38710716 Paper 38701848 Paper 38675783 Paper 38660786 Paper 38656405 Paper 38645097 Paper 38619425 Paper 38591114 Paper 38575599 Paper 38556709 Paper 38554889 Paper 38534917 Paper 38522633 Paper 38503142 Paper 38468295 Paper 38457001 Paper 38436552 Paper 38400526 Paper 38396145 Paper 38381001 Paper 38352859 Paper 38323290 Paper 38303720 Paper 38273376 Paper 38272911 Paper 38226948 Paper 38214087 Paper 38206848 Paper 38199050 Paper 38196575 Paper 38179979 Paper 38117861 Paper 38081412 Paper 38061410 Paper 38051103 Paper 37986783 Paper 37961224 Paper 37949862 Paper 37935566 Paper 37922327 Trial NCT03621124 Trial NCT03220854 Trial NCT02957968 Trial NCT02795819 Trial NCT02349867 Trial NCT02337426 Trial NCT02332928 Trial NCT02270606 Trial NCT01817751 Trial NCT01450384 Trial NCT01417403 Trial NCT01293032 Trial NCT01283178 Trial NCT01050790 Trial NCT00963274 Trial NCT00416975 Trial NCT00107484 Trial NCT00017342 Trial NCT00006456 Trial NCT00006344 Trial NCT00006022 Trial NCT00005580 Trial NCT00003187 Trial NCT00003079 Trial NCT00002818 Patent 7670775

Abstract

The Virginia Commonwealth University (VCU) Massey Cancer Center (MCC) places a high priority on translating the research that arises from each of its programs into pilot and Phase I clinical trials. Recent positive actions to formalize and accelerate translation of pre-clinical science have resulted in an increase in the number of early phase clinical investigator-initiated clinical trials developed at MCC. Support for these trials is available through three Clinical Research Nurses and two Data Managers, each of whom has experience in early phase trials. Solicited concepts from the MCC membership are prioritized by a committee composed of senior leaders and clinical trial experts. Concepts identified by this process are considered high priority for rapid translation to the clinic. The development of high priority studies is then facilitated by the assignment of a Clinical Research Nurse to the study team during the early stages of the protocol development. Once the protocol is approved, both the Clinical Research Nurse and the Data Manager provide continuing support.

View original record on NIH RePORTER →